These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959 [TBL] [Abstract][Full Text] [Related]
5. A Novel Mutation in the NBD Domain of Wang L; Wen W; Deng M; Li Y; Sun G; Zhao X; Tang X; Mao H Front Immunol; 2021; 12():674808. PubMed ID: 34248956 [TBL] [Abstract][Full Text] [Related]
6. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Romberg N; Al Moussawi K; Nelson-Williams C; Stiegler AL; Loring E; Choi M; Overton J; Meffre E; Khokha MK; Huttner AJ; West B; Podoltsev NA; Boggon TJ; Kazmierczak BI; Lifton RP Nat Genet; 2014 Oct; 46(10):1135-1139. PubMed ID: 25217960 [TBL] [Abstract][Full Text] [Related]
7. Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC). Asna Ashari K; Parvaneh N; Mirnia K; Ayati M; Saeedi M; Salehzadeh F; Shahrooei M; Sangsari R; Rohani P; Ziaee V Pediatr Rheumatol Online J; 2024 Oct; 22(1):90. PubMed ID: 39425177 [TBL] [Abstract][Full Text] [Related]
12. NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus. Wang Q; Ye X; Zheng W; Jin T; Zhou Y; Hu X; Zhou Q; Yu X Clin Immunol; 2023 Oct; 255():109731. PubMed ID: 37567492 [TBL] [Abstract][Full Text] [Related]
13. Novel NLRC4 Mutation Causes a Syndrome of Perinatal Autoinflammation With Hemophagocytic Lymphohistiocytosis, Hepatosplenomegaly, Fetal Thrombotic Vasculopathy, and Congenital Anemia and Ascites. Liang J; Alfano DN; Squires JE; Riley MM; Parks WT; Kofler J; El-Gharbawy A; Madan-Kheterpal S; Acquaro R; Picarsic J Pediatr Dev Pathol; 2017; 20(6):498-505. PubMed ID: 28403691 [TBL] [Abstract][Full Text] [Related]
15. A clinical update on inflammasomopathies. Sönmez HE; Özen S Int Immunol; 2017 Nov; 29(9):393-400. PubMed ID: 28387826 [TBL] [Abstract][Full Text] [Related]
16. Too much of a good thing: NLRC4 and autoinflammation. Anderson MS J Exp Med; 2014 Nov; 211(12):2329. PubMed ID: 25403807 [No Abstract] [Full Text] [Related]
17. NLRC4, inflammation and colorectal cancer (Review). Tong G; Shen Y; Li H; Qian H; Tan Z Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239759 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome. Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F Front Immunol; 2018; 9():2162. PubMed ID: 30319625 [TBL] [Abstract][Full Text] [Related]
20. Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype. Volker-Touw CM; de Koning HD; Giltay JC; de Kovel CG; van Kempen TS; Oberndorff KM; Boes ML; van Steensel MA; van Well GT; Blokx WA; Schalkwijk J; Simon A; Frenkel J; van Gijn ME Br J Dermatol; 2017 Jan; 176(1):244-248. PubMed ID: 27203668 [No Abstract] [Full Text] [Related] [Next] [New Search]